• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Latest
  • Videos
  • Series
  • E-Newsletters
    • Fat Tail Daily
    • James Cooper’s Mining Memo
    • The Daily Reckoning Australia
  • Categories
    • Commodities
    • Macro
    • Market Analysis
    • Small Caps
    • Technology
  • Investment Guides
  • Premium Services
  • Editors
  • About
  • Contact Us
Fat Tail Daily
Subscribe
  • Home
  • Latest
  • Videos
  • E-Newsletters
  • Premium Services

Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations

ASX MXC Share Price - MGC Pharmaceuticals Share Price

MGC Pharmaceuticals Share Price Flat After Spike Following Trial Results

At the time of writing, the share price of MGC Pharmaceuticals Ltd [ASX:MXC] is flat, trading at 3.2 cents a share. After a slide that persisted through to December, the MXC share price subsequently rose sharply this month…

By Lachlann Tierney, Tuesday, 15 December 2020

ASX MSB Share Price - Mesoblast Shares

Mesoblast Share Price Crashes on Heart Failure Therapy Results

Mesoblast Ltd [ASX:MSB] shares have taken a heavy hit today on the back of phase three chronic heart failure results for its rexlemestrocel-L therapy. The Mesoblast share price has tracked fairly well this year…

By Lachlann Tierney, Tuesday, 15 December 2020

ASX Cannabis Stocks Down - Time to Invest?

Botanix Share Price Rises 4% as Clinical Study Is Finalised (ASX:BOT)

The pot stock resurgence isn’t slowing down yet! Cannabis companies are still going strong. With biotech-focused Botanix Pharmaceuticals Ltd [ASX:BOT] leading the charge this morning…

By Ryan Clarkson-Ledward, Monday, 14 December 2020

ASX IMM Share Price - Immutep Shares

Immutep Shares Soar 57% Higher Thanks to Two Big Announcements

Small-cap immunotherapy company Immutep Ltd [ASX:IMM] is absolutely flying today. The IMM share price is up 57.14% at time of writing. Spiking on some fantastic news the company had to share this morning….

By Ryan Clarkson-Ledward, Thursday, 10 December 2020

ASX MSB - Mesoblast Share Price

Mesoblast Share Price Up on FDA ‘Fast Track’ Designation (ASX:MSB)

At time of writing the Mesoblast Ltd [ASX:MSB] share price is up 7.26%. Soaring on the back of some exciting news. Their remestemcel-L treatment has secured ‘fast track’ status from the US Food & Drug Administration (FDA)…

By Ryan Clarkson-Ledward, Wednesday, 02 December 2020

ASX RAC - Race Oncology Share Price

Race Oncology Share Price Reaches New High (ASX:RAC)

At time of writing the RAC share price is trading at $2.12 up 7.07%. Race Oncology Ltd (ASX:RAC) announced the initiation of a breast cancer clinical trial program…

By Carl Wittkopp, Friday, 27 November 2020

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Interim pages omitted …
  • Page 28
  • Go to Next Page »

Primary Sidebar

Technology Categories

  • Technology
  • Artificial Intelligence
  • Bitcoin
  • Cryptocurrency
  • Energy
  • Financial Technology
  • Bio Technology

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988